Neogen Chemicals Limited
NSE:NEOGEN.NS
2185.3 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,906.7 | 6,861.8 | 4,872.5 | 3,364.155 | 3,061.217 | 2,390.582 | 1,611.6 | 1,100.67 | 1,003.01 | 839.19 | 738.1 |
| Cost of Revenue
| 4,673.6 | 3,885.1 | 3,474.8 | 2,394.297 | 2,179.827 | 1,708.816 | 1,162.46 | 788.31 | 746.9 | 615.56 | 546.04 |
| Gross Profit
| 2,233.1 | 2,976.7 | 1,397.7 | 969.858 | 881.39 | 681.766 | 449.14 | 312.36 | 256.11 | 223.63 | 192.06 |
| Gross Profit Ratio
| 0.323 | 0.434 | 0.287 | 0.288 | 0.288 | 0.285 | 0.279 | 0.284 | 0.255 | 0.266 | 0.26 |
| Reseach & Development Expenses
| 34.9 | 56.6 | 47 | 29.373 | 20.413 | 14.014 | 8.906 | 6.02 | 4.61 | 4.23 | 4.88 |
| General & Administrative Expenses
| 0 | 144.7 | 108.5 | 75.02 | 76.384 | 52.471 | 28.3 | 23.95 | 23.13 | 22.18 | 21.43 |
| Selling & Marketing Expenses
| 0 | 142.8 | 111.2 | 50.508 | 52.011 | 79.418 | 43.91 | 32.08 | 40.32 | 27.27 | 20.87 |
| SG&A
| 1,361.3 | 287.5 | 219.7 | 125.528 | 128.395 | 131.889 | 72.21 | 56.03 | 63.45 | 49.45 | 42.3 |
| Other Expenses
| 74.7 | 44.5 | 1.3 | 0.016 | 0.015 | 1.857 | 42.4 | 0.29 | 0.02 | 0.48 | 2.67 |
| Operating Expenses
| 1,361.3 | 2,022.5 | 651.6 | 395.292 | 353.284 | 271.8 | 178.62 | 123.61 | 118.82 | 106.41 | 85.9 |
| Operating Income
| 871.8 | 999.7 | 228.3 | 574.566 | 528.106 | 409.966 | 270.52 | 188.75 | 137.29 | 117.22 | 106.16 |
| Operating Income Ratio
| 0.126 | 0.146 | 0.047 | 0.171 | 0.173 | 0.171 | 0.168 | 0.171 | 0.137 | 0.14 | 0.144 |
| Total Other Income Expenses Net
| -345.9 | -289.4 | -40.9 | -132.407 | -117.138 | -117.423 | -97.17 | -73.69 | -52.48 | -36.57 | -44.27 |
| Income Before Tax
| 525.9 | 710.3 | 570.1 | 442.159 | 410.968 | 292.543 | 173.35 | 115.06 | 84.81 | 80.65 | 61.89 |
| Income Before Tax Ratio
| 0.076 | 0.104 | 0.117 | 0.131 | 0.134 | 0.122 | 0.108 | 0.105 | 0.085 | 0.096 | 0.084 |
| Income Tax Expense
| 171.2 | 210.6 | 124.4 | 128.843 | 124.403 | 83.074 | 68.38 | 38.23 | 33.01 | 29.8 | 25.46 |
| Net Income
| 356.5 | 499.7 | 446.3 | 313.3 | 286.565 | 209.469 | 104.97 | 76.83 | 51.8 | 50.85 | 36.43 |
| Net Income Ratio
| 0.052 | 0.073 | 0.092 | 0.093 | 0.094 | 0.088 | 0.065 | 0.07 | 0.052 | 0.061 | 0.049 |
| EPS
| 13.96 | 20.04 | 17.9 | 13.43 | 12.28 | 10.43 | 5.25 | 3.83 | 2.58 | 2.53 | 1.81 |
| EPS Diluted
| 13.96 | 20.04 | 17.9 | 13.43 | 12.28 | 10.43 | 5.25 | 3.83 | 2.58 | 2.53 | 1.81 |
| EBITDA
| 1,100.5 | 1,161.7 | 861.1 | 640.505 | 572.95 | 435.388 | 286.85 | 195.06 | 142.94 | 130.78 | 115.76 |
| EBITDA Ratio
| 0.159 | 0.169 | 0.177 | 0.19 | 0.187 | 0.182 | 0.178 | 0.177 | 0.143 | 0.156 | 0.157 |